Modern approaches for developing antivirals against SARS-CoV 2
Modern approaches for developing antivirals against SARS-CoV 2 is a science project.
Press Enter · cited answer in seconds
0 sources
Key Facts
- Start time: August 1, 2020[1]
- End time: July 31, 2025[2]
- Participant: eu_cordis_org:999755818[3], eu_cordis_org:999955541[4], eu_cordis_org:999919263[5], University of Giessen[6], eu_cordis_org:896048753[7], eu_cordis_org:951869343[8], eu_cordis_org:999528450[9], eu_cordis_org:940156593[10], eu_cordis_org:999681225[11], Medical University of Vienna[12]
- Short name: MAD-CoV 2[13]
- Budget: 6405168.75 euro[14]
- Funding scheme: Horizon 2020[15]